Diabetes research and clinical practice
Effects of liraglutide treatment for 35-days on total and regional fat, lean, and bone mass, and on the Myostatin-Activin-Follistatin-IGF-1 axes: a secondary analysis of a randomized placebo-controlled crossover study.
Valeria Gutierrez de Piñeres, Arantxa Ramirez-Cisneros, Claudia S Tamayo-Torres, Angeliki M Angelidi, Marianthi Kavelidou, Konstantinos Stefanakis, Christos S Mantzoros
Published: 202610.1016/j.diabres.2026.113113
Abstract
BACKGROUND: Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are used to treat obesity and metabolic diseases, yet their early impact on body composition and circulating regulators of muscle and bone remain unclear. This study aimed to assess ear…
Preview only. Read the full abstract at the source